These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10547547)

  • 1. Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion.
    Rossi CR; Foletto M; Di Filippo F; Vaglini M; Anza' M; Azzarelli A; Pilati P; Mocellin S; Lise M
    Cancer; 1999 Nov; 86(9):1742-9. PubMed ID: 10547547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
    Di Filippo F; Garinei R; Anzà M; Cavaliere F; Giannarelli D; Cagol PP; Rossi CR; Santinami M; Deraco M; Botti C; Perri P; Di Filippo S; Piarulli L; Bruno P
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study.
    Di Filippo F; Rossi CR; Vaglini M; Azzarelli A; Anzà M; Santinami M; Lise M; Cavaliere F; Giannarelli D; Quagliuolo V; Vecchiato A; Deraco M; Garinei R; Foletto M; Botti C; Cavaliere R
    J Immunother; 1999 Sep; 22(5):407-14. PubMed ID: 10546156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
    In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Doxorubicin in antiblastic hyperthermic perfusion in the treatment of advanced soft-tissue sarcoma of the limbs].
    Di Filippo F; Patrizi V; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Filippo S; Vespa A
    Suppl Tumori; 2005; 4(3):S126-7. PubMed ID: 16437946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas.
    Rossi CR; Vecchiato A; Foletto M; Nitti D; Ninfo V; Fornasiero A; Sotti G; Tregnaghi A; Melanotte P; Lise M
    Cancer; 1994 Apr; 73(8):2140-6. PubMed ID: 8156518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
    Rossi CR; Mocellin S; Pilati P; Foletto M; Campana L; Quintieri L; De Salvo GL; Lise M
    Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic isolated perfusion with low-dose TNFalpha and doxorubicin in patients with locally advanced soft tissue limb sarcomas.
    Rossi CR; Foletto M; Mocellin S; Pilati P; Quintieri L; De Salvo GL; Nitti D; Lise M
    J Chemother; 2004 Nov; 16 Suppl 5():58-61. PubMed ID: 15675481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient.
    Bonvalot S; Rimareix F; Causeret S; Le Péchoux C; Boulet B; Terrier P; Le Cesne A; Muret J
    Ann Surg Oncol; 2009 Dec; 16(12):3350-7. PubMed ID: 19830495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience.
    Rastrelli M; Campana LG; Valpione S; Tropea S; Zanon A; Rossi CR
    Int J Hyperthermia; 2016; 32(2):165-72. PubMed ID: 26608883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal doxorubicin in the perfusional treatment of advanced soft tissue limb sarcoma.
    Di Filippo F; Cavaliere F; Anzà M; Garinei R; Botti C; Perri P; Di Angelo P; Patrizi V; Di Filippo S; Visca P
    J Chemother; 2004 Nov; 16 Suppl 5():66-9. PubMed ID: 15675483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adriamycin in hyperthermic perfusion for advanced limb sarcomas.
    Rossi CR; Vecchiato A; Da Pian PP; Nitti D; Lise M; Melanotte PL; Turra S; Vigliani F
    Ann Oncol; 1992 Apr; 3 Suppl 2():S111-3. PubMed ID: 1622851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.
    Deroose JP; Eggermont AM; van Geel AN; Burger JW; den Bakker MA; de Wilt JH; Verhoef C
    J Clin Oncol; 2011 Oct; 29(30):4036-44. PubMed ID: 21931039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
    Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
    Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha and doxorubicin in hyperthermic perfusion for limb sarcomas.
    Rossi C; Foletto M; Vecchiato A; Menin N; Pizzirani E; Difilippo F; Vaglini M; Santinami M; Azzarelli A; Cavaliere R; Lise M
    Oncol Rep; 1996 Nov; 3(6):1059-61. PubMed ID: 21594507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.
    Eggermont AM; Schraffordt Koops H; Klausner JM; Kroon BB; Schlag PM; Liénard D; van Geel AN; Hoekstra HJ; Meller I; Nieweg OE; Kettelhack C; Ben-Ari G; Pector JC; Lejeune FJ
    Ann Surg; 1996 Dec; 224(6):756-64; discussion 764-5. PubMed ID: 8968230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
    Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermic antiblastic perfusion with TNFalpha and melphalan in stage III limb melanoma patients: A phase I - II SITILO study.
    Di Filippo F; Rossi CR; Garinei R; Anzà M; Cavaliere F; Botti C; Perri P; Di Filippo S; Di Angelo P; Principi F; Laurenzi L
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):97-101. PubMed ID: 16767914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
    Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB
    Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
    Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.